Fmr LLC Ironwood Pharmaceuticals Inc Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Fmr LLC holds 135,592 shares of IRWD stock, worth $607,452. This represents 0.0% of its overall portfolio holdings.

Number of Shares

135,592

Previous 89,363 51.73%

Holding current value

$607,452

Previous $778,000 13.62%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$5.58 - $8.61 $257,957 - $398,031	46,229 Added 51.73%	135,592 $884,000
Q1 2024 May 13, 2024	SELL	$8.32 - $15.45 $70,603 - $131,108	-8,486 Reduced 8.67%	89,363 $778,000
Q4 2023 Feb 13, 2024	BUY	$8.79 - $11.51 $718,925 - $941,391	81,789 Added 509.27%	97,849 $1.12 Million
Q3 2023 Nov 13, 2023	SELL	$8.25 - $11.35 $41,943 - $57,703	-5,084 Reduced 24.04%	16,060 $154,000
Q2 2023 Aug 11, 2023	BUY	$10.1 - $11.6 $21,755 - $24,986	2,154 Added 11.34%	21,144 $224,000
Q1 2023 May 11, 2023	SELL	$10.37 - $12.56 $2,571 - $3,114	-248 Reduced 1.29%	18,990 $199,000
Q4 2022 Feb 13, 2023	SELL	$9.9 - $12.43 $794,445 - $997,470	-80,247 Reduced 80.66%	19,238 $238,000
Q3 2022 Nov 10, 2022	BUY	$10.14 - $12.38 $743,616 - $907,887	73,335 Added 280.44%	99,485 $1.03 Million
Q2 2022 Aug 12, 2022	SELL	$11.05 - $12.72 $181,695 - $209,154	-16,443 Reduced 38.6%	26,150 $301,000
Q1 2022 May 13, 2022	BUY	$10.61 - $12.88 $389,768 - $473,159	36,736 Added 627.22%	42,593 $536,000
Q4 2021 Feb 14, 2022	SELL	$10.86 - $13.95 $4,202 - $5,398	-387 Reduced 6.2%	5,857 $68,000
Q3 2021 Nov 15, 2021	SELL	$11.92 - $13.92 $4,911 - $5,735	-412 Reduced 6.19%	6,244 $81,000
Q2 2021 Aug 13, 2021	BUY	$10.16 - $13.11 $67,624 - $87,260	6,656 New	6,656 $85,000

Others Institutions Holding IRWD

# of Institutions

247

Shares Held

171M

Call Options Held

11.2M

Put Options Held

28.5K

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $686M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account